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1. Introduction  
Sarcomas of the Head and Neck (SHN) are rare tumors of connective tissue origin that 
comprise less than 1% of head and neck malignancies. SHN account for approximately 5% to 
10% of all sarcomas (Bruce, 2004). They arise in any soft tissue or osseous tissues of the region 
and may be found in patients of any age or gender. This chapter we will present the essential 
elements of diagnosis and resection or neck dissection of head and neck sarcoma. 
Diagnosis of SHN is a diagnostic challenge. Although biopsy by FNA identified the correct 
specific sarcoma type in only 21% of cases, FNA led to an appropriate diagnostic biopsy in 
88% (Costa et al., 1996). In only 7% of cases were the FNA findings misleading (benign or 
inflammatory) and in 5% of cases the reading was interpreted as inadequate. More recently, 
FNA biopsies of sarcoma were more often interpreted as showing a lower grade than that 
determined by final analysis of the fully resected specimen (Jones et al. 2002). Superficial and 
accessible lesions or lesions with inconclusive results from prior closed biopsy should be 
biopsied by incisional or excisional technique; fine needle aspiration or core needle biopsy 
should be reserved for deeper and less accessible lesions (Schalow & Broecker, 2003). 
Frequently the initial procedure for patients with a mass suspected to be Rabdomyosarcoma is 
a biopsy, usually open, which obtains an adequate specimen for pathological, biological and 
treatment protocol studies. There may be instances when core needle biopsy is appropriate, 
such as metastatic disease or small lesions in areas that will be treated primarily by 
chemotherapy and radiotherapy (Rodeberg et al, 2002). Since lymphoma and nasopharyngeal 
carcinoma would show the same signal intensity characteristics as sarcomas on magnetic 
resonance, tissue biopsy is imperative for correct diagnosis (Flympas et al. 2009). 
The main therapy for soft tissue sarcomas of the head and neck is en-bloc resection with a 
margin of normal tissue. The adequacy of surgical resection seems to be a major 
determinant of outcome for sarcomas. The difficulty with en-bloc resection in these tumors 
relates to the proximity of important neurovascular structures and vital organs, as well as 
the cosmetic and functional morbidity resulting from such radical extirpative procedures. It 
is known that some soft-tissue sarcomas develop a pseudocapsule as a result of compression 
of adjacent tissues. This may obscure the true invasive nature of these neoplasms. Sarcomas 
tend to extend outside this pseudocapsule and invade tissues that may seem uninvolved 
during surgery. Because of the anatomical challenges of en-bloc resection for soft tissue 
sarcomas of the head and neck, positive margins should prompt the addition of adjuvant 
radiotherapy. Death from SHN is often a consequence of uncontrolled local disease as it is 
from metastases, unlike other sarcomas where local salvage options are often available. 
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Most soft tissue sarcoma spread in a longitudinal direction within the muscle groups where 
they originate. They generally respect barriers to tumor spread, such as bones, interosseous 
membrane, major fascial planes, etc, and this feature should be exploited in planning tissue 
preserving approaches to management. As they extend, lesions invade muscle and 
contiguous structures or other vital anatomy (de Bree et al, 2010).  
 Most SHN present with localized disease with metastasis being present in fewer than 10% of 
cases at the time of diagnosis and initial treatment. Predominant risk is to the lungs. Lymph 
node metastasis is considered an infrequent event in the natural history of soft tissue sarcomas. 
The rarity of such lymph node metastasis has made the study of their natural history difficult. 
Most published series are small, retrospective studies, and as individual studies are hard to 
interpret. The overall incidence of lymph node metastasis was estimated to be 10%. Lymphatic 
spread in sarcomas are rare, and that lymphatic spread is more frequently associated with 
certain histologic types. Those are, rhabdomyosarcomas, epithelioid sarcomas, angiosarcomas, 
and synovial sarcomas. Bone sarcomas may also present with regional lymph node disease, 
which carries a very adverse outcome. (Fong et al, 1993)  
We discuss the previous reports of neck metastasis and neck dissection of main subtypes of 
Head and neck sarcoma. 
1 Rabdomyosarcoma, 2 Fibrous tumor (desmoid tumor, fibrosarcoma, dermatofibrosarcoma 
protuberans), 3 Angiosarcoma 4 Synovial sarcoma, 5 Osteosarcoma, 6 Chondrosarcoma, 7 
Ewing’s sarcoma. 
2. Rabdomyosarcoma 
The rhabdomyosarcoma (RMS), a skeletal muscle subtype, is the most common soft tissue 
sarcoma in children, comprising about 50% of these tumors. In contrast, adult 
rhabdomyosarcomas comprise less than 10% of all soft tissue sarcomas. The head and neck 
are the most common primary sites for RMS in children and teenagers, followed by the 
genitourinary tract, limbs, thorax, and retroperitoneum. The tumor head and neck subsites 
include the orbit, parameningeal sites (nasopharynx, nasal cavity, paranasal sinuses, 
temporal bone, pterygopalatine fossa, and the infratemporal fossa), and non-parameningeal 
sites. Tumors that invade the orbit only have a better prognosis. (Moretti, 2010) 
Subtypes may be histologically classified as: embryonic (which may be subdivided into 
embryonic, botryoid, and spindle cell tumors), alveolar, or pleomorphic. In children, about 
60% are embryonic tumors, 20% are alveolar tumors, 15% are not classified, and 5% are 
pleomorphic tumors. The embryonic subtype has a better prognosis in children, but is more 
aggressive in adults. The alveolar subtype has a poor outcome because of its propensity to 
metastasize at a distance. The pleomorphic subtype occurs predominantly in adults. (World 
Health Organization Classification of Tumours [WHO] Tumors of Soft Tissue and Bone, 2010) 
2.1 Treatment 
Prior to the introduction of antineoplastic drugs, surgery played the central role in the cure of 
patients with RMS; in the last four decades, the development of multi-agent chemotherapy 
protocols resulted in a significant improvement in long-term survival: from 25% in 1970, to 
approximately 70% nowadays. In the head and neck area, a distinction is drawn between 
parameningeal rhabdomyosarcoma (PM-RMS) and RMS of other localizations. RM-RMS arises 
at sites with a particularly close anatomic relationship with the meninges such as 
nasopharynx, nasal cavity, paranasal sinuses, middle ear and mastoid, infratemporal and 
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pterygopalatine fossa. They represent a particular surgical challenge. Surgical excision may 
lead to unacceptable mutilations and incomplete resection in most cases. These tumours have 
a high likelihood of meningeal extension, which is considered a fatal pattern of progression. 
Most authors conclude that multi-agent chemotherapy combined with radiation is the primary 
treatment modality offered to children with PM-RMS. Surgery prior to chemotherapy is 
recommended if there is no intracranial extension, if complete resection seems feasible and if it 
won’t lead to unacceptable morbidity. (Gradoni, et al. 2010)  
2.2 Lymphatic metastasis and neck dissection 
Head and neck RMS has proven able to spread to cervical lymph nodes. Comparing the two 
most frequent histologic subtypes i.e. embryonal and alveolar, the latter showed a higher 
tendency to metastasize through the lymphatic route. According to some authors, elective 
treatment of the neck is not justified. In view of the low incidence of cervical lymph node 
metastases of merely 3% according to the IRS (Intergroup Rhabdomyosarcoma Study), 
Rodeberg et al. saw no indication for conducting elective neck dissection (Rodeberg et al.2002). 
Wurm recommends elective neck dissection in patients with alveolar RMS when surgery on 
primary tumour is planned (Wurm, 2005). Callender et al. found regional metastasis in 15–38% 
of their patients respectively and inferred that elective neck dissection offers a benefit 
(Callender, 1995). Controversy exists also over treating the N+ neck with additional 
radiotherapy or neck dissection. If nodes are metastatic and complete primary tumour 
resection is feasible, neck dissection is recommended; while, if the lymph nodes are positive 
but the primary tumour is unresectable, they should be included in the radiotherapy field.  
2.3 Case report 
An 22 year-old female, who had been treated for retinoblastoma at six months of age, 
presented for evaluation of left temporal swelling. She had underwent enucleation of the 
bilateral eyeball and 40 Gy irradiation to the left orbit at 1 years of age. Examination 
revealed a firm mass overlying the left temporal muscle (Figure 1) and left cervical  
 
Fig. 1. A 22-year-old female case of Rabdomyosarcoma, infantile type of the temporal 
muscle (arrow). She underwent the convination of chemotherapy and radiation 9 years ago, 
now she was free of disease. (Our experience case) 
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lymphadenopathy. Biopsy revealed that the tumor was Rabdomyosarcoma, embryonal 
type. Metastatic work-up was negative including lumber puncture, bone scan ,and chest CT. 
The patient received treatment with chemotherapy consisting of vincristine 2 mg/m2 , 
actinomycin D 0.5 mg/m2,and cyclophosphamide 2.2g/m2 (VAC) every 3 weeks for 13 
courses. Also she was irradiated 24Gy between 5 courses and 6 courses.  She was followed 
closely after completing chemotherapy. The patient was alive and well with no evidence of 
disease 80 months after last treatment. 
3. Fibrous tumor (Malignant fibrous histiocytoma, Desmoid tumor, and 
Fibrosarcaoma) 
Since the late 1970s malignant fibrous histiocytoma (MFH) were the most common soft 
tissue sarcoma of middle and late adulthood. The existence of “malignant fibrous 
histiocytoma” as a distint entity is now considered controversial and at best is regarded ad a 
heterogeneous group of tumors without a specific known line of differentiation. Current 
nomenclature recognizes the entities undifferentiated high grade pleomorphic sarcoma, and 
myxofibrosarcoma (Montgomery et al. 2009). 
Desmoid tumors, or aggressive deep-seated fibromatosis, are part of a rare group of fibrous 
tissue proliferations which tend to be locally aggressive but have no propensity for 
metastasis. Desmoid tumors are uncommon and slow-growing tumors with a propensity for 
recurrence even after complete resection. The natural history of desmoid tumors is not well-
defined and poorly understood. Location of tumors can limit therapeutic options and result 
in significant morbidity with or without surgical resection. While there is no risk of 
degeneration from fibromatosis to fibrosarcoma, this is a distinct type of soft tissue 
sarcoma.Unfortunately, there are also no distinct clinical characteristics of fibrosarcoma, and 
disease is poorly described in the context of all fibroblastic tumors. Classic fibrosarcomas are 
seen in persons aged 30–55 years. Fibrosarcomas can be part of the spectrum of radiation-
induced or radiation-associated sarcomas, representing about 15% of the histologic 
subtypes. Treatment options are dictated by location, and surgical resection remains the 
mainstay of curative therapy. Dermatofibrosarcoma protuberans (DFSP) is a specific form of 
soft tissue sarcoma which is nearly always considered a low-grade sarcoma. These tumors 
are prone to recurrence, with high local recurrence rates of up to 60% following  
resection. Occasionally, DFSP will undergo transformation to classic fibrosarcoma (Wong et 
al, 2008).  
3.1 Treatment 
The management of soft tissue sarcomas in the head and neck is primarily surgical. 
Sarcomas also tend to growth along fascial planes. For these reasons, the surgical 
resection of sarcomas require a wide resection which respects fascial compartments and 
includes a generous amount of uninvolved tissue beyond the tumour margins. For most 
cancer types, a 2.0- to 3.0-cm margin including resection of the underlying fascia is 
recommended. The critical anatomy of the head and neck limits the capacity to obtain 
these wide surgical margins. Sarcomas arising in the head and neck have a higher local 
recurrence rate and a worse disease-specific survival than sarcomas arising at other sites. 
(Brockstein, 2004) 
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3.2 Lymphatic metastasis and neck dissection 
The incidence of lymph node metastasis of fibrosarcoma was found to be 4.4-5.1 %. It is 
generally agreed that because of the rarity of lymph node metastasis, elective neck 
dissection for fibrosarcoma is generally not indicated. (Fong et al, 1993) 
3.3 Case report 
A 62-year-old male was referred to our hospital for the left neck mass. He had been 
underwent the removal of the left neck mass and the pathological diagnosis was extra-
abdominal desmoid. A MRI showed the high intensity mass of the Gd-enhanced T1 
weighted image in the Level III area and infiltrate to the surrounding muscles (figure 2). He 
was underwent the removal of the tumor, encased by the sternocleidmastoid muscle and 
deep cervical muscles, with preservation of the internal juglar vein and phenic nerve. He 
was free of disease after the 3 years.  
 
Fig. 2. A 62-year-old male case of desmoid. He underwent the removal encased by the 
surrounding muscles. After the 3 years operation, now he was free of disease. (Our 
experience case) 
4. Angiosarcoma 
Angiosarcomas are a subtype of soft-tissue sarcoma and are aggressive, malignant 
endothelial-cell tumors of vascular or lymphatic origin (Young et al, 2010). Treatment is 
challenging in many cases and the prognosis is poor. Angiosarcoma can arise in any soft-
tissue structure or viscera and cutaneous angiosarcomas typically involve the head and 
neck, particularly the scalp (27%). Angiosarcomas are subdivided into cutaneous 
angiosarcoma, lymphoedema-associated angiosarcoma, radiation-induced angiosarcoma, 
rimary-breast angiosarcoma, and soft-tissue angiosarcoma, and most reports include several 
angiosarcoma subtypes. There is some evidence that tumor behaviour might depend on site 
of origin, although whether differences between cutaneous, radiation induced, breast, and 
visceral angiosarcomas are caused by biological differences or differences in clinical 
presentation and treatment is unclear.  
4.1 Treatment  
There are no randomised trials and few prospective studies, most published reports of 
angiosarcoma treatment are retrospective case series. Treatment has been included in 
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management guidelines for other soft tissue sarcomas. Radical surgery with complete 
resection is the primary treatment of choice. Involved margins resection are common because 
of the invasive and often multifocal nature of angiosarcomas, which confer a worse prognosis. 
Angiosarcomas have an overall 5 year survival of about 35%. Even with localised disease, the 
most optimistic survey suggests only 60% of patients survive for more than 5 years, with a 
median survival of 7 months (Young,2010). However, there are reports of some long-term 
survivors with metastatic disease, but which prognostic factors are important is unclear.  
4.2 Lymphatic metastasis and neck dissection 
The incidence of lymph node metastasis of angiosarcoma was found to be 13.5 % (Fong, 
2010). Angiosarcoma is  particularly prone to nodal metastasis. Prognosis of such metastasis 
is poor, but certainly not hopeless. Neck dissection is appropriate treatment for isolated 
metastasis to regional lymph nodes and might provide long-term survival. 
5. Synovial sarcoma 
Synovial sarcoma is a malignant soft-tissue neoplasm uncommonly found in the head and 
neck. Although synovial sarcoma is usually found near large joints and bursae of the 
extremities, it rarely arises from synovial membranes. It accounts for approximately 8% of all 
soft-tissue sarcomas. Only 10% of all synovial sarcomas occur in the head and neck, and these 
rarely have an obvious association with synovial structures (Amble et al,1997). Synovial 
sarcoma were most commonly located in the neck (60%); thus, the most common symptoms 
were a neck mass and neck pain. Ninety percent of Synovial sarcoma have an identifiable 
translocation between chromosomes 18 and X that results in the fusion of the SYT gene on 
chromosome 18 and the SSX-1 or SSX-2 gene on chromosome X (Harb et al, 2007). 
5.1 Treatment  
As with other soft tissue sarcomas, radical surgery with complete resection is the primary 
treatment of choice. Unfortunately, up to 50% of Synovial sarcoma recur, usually within 
2years. Some 40% metastasis, commonly to lungs and bone and also regional lymph nodes. 
The best outcome are in childfood patients, in tumors which are <5cm in diameter, have   
< 10 mitoses/ 10 hpf and no necrosis, and when the tumor is eradicated loccaly. 
(Christopher et al, 2010) 
5.2 Lymph node metastasis and neck dissection  
Although not normally a feature of sarcomas, metastasis to regional lymph nodes occurs in 
12.5% of cases of synovial sarcoma in the head and neck and 23% of cases in the extremities 
(Roth et al, 1975). Neck dissection is appropriate treatment for isolated metastasis to regional 
lymph nodes and may provide long-term survival.  
6. Osteosarcoma 
Osteosarcoma is the most common primary malignancy of bone. These tumors typically 
originate in the extremities and the pelvis, with only 6–10% of patients presenting with a 
head and neck primary tumor (Russell et al, 2003). The mandible and maxilla are the 
predominate locations of head and neck osteosarcoma (HNOS), although extragnathic bone 
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as well as soft tissues sites may be affected. The peak age of incidence for osteosarcoma 
outside the head and neck is in the adolescent years. In contrast, HNOS most commonly 
affects patients in their 30s. Distant metastases have been reported in 10–20% of patients 
with HNOS, compared with 53–75% of patients with disease arising outside the head and 
neck. The 5-year, disease-specific survival rate for patients with HNOS has been poor, with 
most studies reporting survival rates of 23–37%. Management of osteosarcoma outside the 
head and neck prior to the standardized use of chemotherapy resulted in worse 5-year 
survival rates of 10–20%.It is widely accepted that wide surgical excision is the mainstay of 
therapy for patients with HNOS. Adjuvant treatment with radiotherapy and/or 
chemotherapy also has been administered. For patients with osteosarcoma arising outside 
the head and neck, surgery also is considered a key component in therapy, but the addition 
of neoadjuvant and/or adjuvant chemotherapy has improved survival markedly. The Multi-
Institution Osteosarcoma Study identified an increase in the 6-year, event-free survival rate 
from 11% with surgery alone to 61% when chemotherapy was given postoperatively.13 
Over the last 2 decades, the standard therapy for patients with non–head and neck 
osteosarcoma has evolved to routinely include both neoadjuvant and adjuvant 
chemotherapy. With these regimens, long-term survival rates of 70–80% are being obtained. 
Whether these same results can be obtained in patients with HNOS is not yet known. 
6.1 Treatment  
The mainstay of treatment of head and neck osteosarcoma is surgery. Adjuvant 
postoperative RT is indicated for those with close or positive margins. The role of adjuvant 
chemotherapy is unclear.  
6.2 Lymph node metastasis and neck dissection  
The AJCC (2010) definitions of TNM showed that any regional lymph node metastasis  (N1) 
classified to Stage IVB. It suggested to the extremely poor prognosis in front of the neck 
metastasis of the osteosarcoma. In rare case, Extraskeletal osteosarcoma was present ,That is 
a high-grade malignant sarcomas defined (1) soft tissue origin and no attachment to the 
bone or periosteum, (2) a uniform sarcomatous pattern (to exclude the possibility of a mixed 
malignant mesenchymal tumor), with production of osteoid and/or cartilage matrix. We 
reported a young patient with highly malignant HNOS, which was excised but was 
subsequently complicated by local and distant metastases.(Saito et al,2008)  
6.3 Case report 
A 17-year-old Japanese man with no history of trauma or irradiation was referred to the 
hospital with complaints of a swelling in the left side of the neck that had been gradually 
increasing in size. Physical examination showed a smooth, stony hard, mobile mass measuring 
24 x 30 mm in the left submandibular region. A computed tomographic scan (figure 3) showed 
a calcified mass measuring 23 x 18 mm in size, unattached to the hyoid bone or the mandible. 
The tumor was mildly adherent to the suprahyoid muscles. It was excised along with 
surrounding muscle. The surgical margin was free of in the direction of the hyoid bone. Three 
months after the operation, the patient developed massive local recurrence of the tumor. We 
removed the tumor encased by the surrounding muscles. Postoperatively, the patient received 
a course of radiotherapy. However, 4 months after the second operation, he developed left 
facial nerve palsy and complained of sudden hearing loss on the left side. A CT scan showed 
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tumor recurrence in the temporal bone, occupying the middle cranial fossa. The patient and 
his family selected chemotherapy instead of surgery, but 1month after the start of 
chemotherapy consisting of Cisplatin 125mg/body and Pirarubicin 60mg/body, the patient 
developed intracranial hemorrhage and died of hydrocephalus.  
 
Fig. 3. A case of extraskeletal osteosarcoma of 17-year-old male. (Our experienced case) 
7. Chondrosarcoma 
Chondrosarcoma is a malignant tumor in which the tumor cells form chondroid (cartilage) 
but not osteoid. Although chondrosarcoma most commonly arises from either cartilaginous 
structures or bone derived from chondroid precursors, chondrosarcoma may also arise in 
areas where cartilage is not normally found. Skull bones were the predominant tissue 
(59.7%) arose chondrosarcoma. Among these cases were 7.7% originating in the mandible. 
laryngotracheal cases were about 23.4% in all cases. The other sites were oral cavity, 
pharynx, and orbit (Koch et al, 2000). 
These tumors developing in soft tissue presumably arise from cartilaginous differentiation 
of primitive mesenchymal cells. Chondrosarcomas develop more commonly in bone than 
cartilage. However, a sufficiently large number develop from laryngeal cartilage, so that 
chondrosarcoma is the most common sarcoma developing in the larynx.  
It is noteworthy that more than 90% of laryngotracheal chondrosarcoma cases were low 
grade and occurred in older patients (>50 years). These associations suggest that 
laryngotracheal tumors represent a form of chondrosarcoma that should be distinguished 
from cases arising in osseous sites of the head and neck that are more commonly 
characterized by a younger age and a higher grade. The recognized difficulty in 
discriminating between the benign laryngeal chondromatous lesions and low-grade 
chondrosarcomas confounds the interpretation of tumor behavior at this site. It is possible 
that the large number of low-grade chondrosarcomas identified within the cartilaginous 
laryngotracheal site may reflect the inclusion of some benign cases erroneously diagnosed as 
cancer. Despite ongoing study, a widely accepted approach to analysis of cytogenic or 
proliferative characteristics has yet to surpass grading as an independent predictor of the 
biologic behavior of chondrosarcoma (Koch et al,2000).  
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7.1 Treatment   
 Head and neck chondrosarcomas are generally slow-growing tumors with an indolent 
course. Yet, owing to the locally aggressive nature and the propensity to recur if not 
adequately treated, most studies recommend wide en bloc surgical resection as the mainstay 
of treatment. Conservative resection of low-grade lesions of the larynx has been proven 
effective in several reports. Organ preservation may be archived with such an approach, 
which has important functional outcome implications (Hong et al, 2009).  
7.2 Lymph node metastasis and neck dissection  
In the largest series to date representing 151 cases of chondrosarcoma of the head and neck, 
Weiss and Bennett noted that “metastasis is not common and generally occurs late in the 
disease, usually after multiple surgical manipulations.”(Weiss & Bennett, 1986) Mark et al 
stated that “only 1/18 (5%) patients recurred in regional lymph nodes without elective neck 
treatment, further justifying the accepted approach of not electively treating the neck in 
head and neck sarcomas.”(Mark et al, 1993)  
7.3 Case report  
A 55-year-old female was referred to us in 2003 because of a 2-years history of hoarseness. 
She also complained about having dyspnea and had underwent tracheostomy. Direct 
laryngoscopy revealed a smooth, firm subglottic mass at the subglottis. The CT scan showed 
a mass that had eroded almost half of the left cricoid cartilage (Figure 4), and the biopsy 
revealed chondroma. An excision of the tumor and 4/5 cricoid cartilage was resected. A 
tracheofissure was done at the end of the operation to put a stent T tube in place. 
Histopathologic examination of the surgical specimen confirmed a grade I chondrosarcoma. 
27 months later, direct laryngoscopy was done with no evidence of recurrence. Afterall, we 
reconstructed the anterior wall of trachea by the costal cartilage. Up until now, the patient 
has been followed up regularly. In May 2011, 8 years after surgery, she was in perfect health 
except for a paralysis of the left vocal cord. 
 
Fig. 4. A case of laryngeal chondrosarcoma of 40-year-old female. She was underwent 
operation with laryngeal preservation 9 years ago. Now she was free of disease with 
laryngeal function. (Our experienced case) 
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8. Ewing’s sarcoma 
Ewing’s sarcoma arising in the head and neck region is extremely rare, comprising 1-4% of 
all cases of Ewing’s sarcoma. Most authors claim a better prognosis for Ewing’s sarcoma of 
the head and neck region as compared to that arising in other anatomic locations. The most 
commonly affected bones in the head and neck region are the skull, the mandible and the 
maxilla. There has also been case reports of localized Ewing’s sarcoma affecting the orbital 
roof, the retropharynx and the nasal cavity (Allam et al, 1999). 
8.1 Treatment  
Surgery after chemotherapy is the current standard of cure. Despite the lack of randomized 
trials comparing different local treatment modalities in Ewing’ Sarcoma, wide surgical 
resection is considered the treatment of choice. It reduces the local relapse rate, improves the 
overall survival and may avoid radiotherapy. Ludwig affirms that chemotherapy alone is an 
ineffective measure in achieving local control of disease (Ludwig, 2008). Thus, it is 
commonly accepted that an attempt at complete tumour resection should always be made. 
Nevertheless chemoradiation may be a reasonable alternative to surgery for treatment of 
tumours that are resectable only with an unacceptable degree of mutilation.  
8.2 Lymph node metastasis and neck dissection  
Lymphnodes metastasis from Ewing’s sarcoma are very rare. The nodal status included as a 
prognostic indicator in the American Joint Committee on Cancer (AJCC) staging system has 
even been considered irrelevant by some authors. Considering this, it can be argued that 
elective neck dissection is not indicated. Nevertheless, as best as we could determine, this 
argument is not discussed in the literature. 
9. Conclusion  
Head and neck sarcomas are rare tumors and represent a heterogeneous group of tumours 
of different histological variants. Subtyping of sarcomas is increasingly important because of 
the development of biologic response modifiers. Although traditional morphological 
assessment is the foundation of clinical decision making, immunohistochemistry and 
molecular biology are useful for diagnosis, prognosis and identification of possible targets 
for molecular therapy. The management of sarcomas in the head and neck is primarily 
surgical. Since, in head and neck sarcomas it is difficult to obtain wide margins during 
surgical treatment, because of anatomic constraints, most patients with locally resectable 
tumours undergo post-operative irradiation. Modern reconstructive surgery makes more 
extensively resection possible and may improve local tumour control, while providing 
acceptable cosmetic and functional results. Adjuvant systemic chemotherapy seems to 
improve outcome, but its benefit must be weighted against associated toxicities. Survival of 
patients with head and neck soft tissue sarcoma varies from 50 to 80% and depends on 
prognostic factors as tumour grade, margin status and tumour size. With further insight into 
the biology of soft tissue sarcoma and the combination of new treatment options with 
modern imaging techniques, we will most certainly be able to improve clinical outcome in 
patients with soft tissue sarcoma in the upcoming years.  
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